Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02102828 · ClinicalTrials.gov registry record · NA

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

A NA study of Deep Vein Thrombosis, sponsored by TriHealth.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02102828 is a NA study of Deep Vein Thrombosis that has completed, run by TriHealth. The registered enrollment target is 100 participants, below the 7,927-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02102828, a NA study of Deep Vein Thrombosis, has completed, sponsored by TriHealth.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The Cothera VPulse(tm) mechanical compression device (MCD) combines rapid intermittent sequential compression with cold therapy and is designed for single patient use in the home. Additionally, it can track patient compliance. This study will examine if there is a difference in deep vein thrombosis (DVT) occurrence over 3 weeks after tourniquet-less total knee arthroplasty (TKA) and multimodal prophylaxis with or without extended MCD use in a cooling device/MCD system.

Conditions Studied

Interventions

  • DEVICE extended compression
  • OTHER Aspirin

Study Locations (1)

Ohio

  • Good Samaritan Hosptial - Cincinnati

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-03
Est. Completion 2015-03
Phase NA

Sponsor

TriHealth

81 total trials

What the Registry Record Tells You About NCT02102828

The ClinicalTrials.gov registry entry for NCT02102828 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,927-participant average among 24 other Deep Vein Thrombosis trials with a reported enrollment target (99% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Deep Vein Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which extended compression is the first listed.

NCT02102828 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02102828 about?

NCT02102828 is a clinical study titled "Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty". The Cothera VPulse(tm) mechanical compression device (MCD) combines rapid intermittent sequential compression with cold therapy and is designed for single patient use in the home. Additionally, it can track patient compliance. This study will examine if there is a difference in deep vein thrombosis ...

What is the current status of trial NCT02102828?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-03. Estimated completion is 2015-03.

What conditions does trial NCT02102828 study?

This clinical trial studies the following conditions: Deep Vein Thrombosis.

What interventions are being tested in trial NCT02102828?

The interventions under investigation include: extended compression (DEVICE), Aspirin (OTHER).

Who is sponsoring clinical trial NCT02102828?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02102828 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deep Vein Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.